Search PubMed⌕ Search

Biomedical subjects

G Forche

Publications and source records attributed to G Forche.

At least 19 recordsLinked to original sources

Spirometric reference values for white European children and adolescents: Polgar revisited.

We analyzed six spirometric data sets collected in the Netherlands, Austria, the United Kingdom, Spain, and Italy. The objectives were to establish whether (1) it was possible to describe spirometric indices from childhood to adulthood, taking into account the adolescent growth spurt, and (2) there are systematic differences in ventilatory function between children and adolescents in different parts of Western Europe. The study comprised 2,269 girls and 3,592 boys, aged 6-21 years. The range in standing height was 110-185 in girls, 110-205 in boys. The model applicable to all data sets was ln FVC or ln FEV1 = a + (b + c x A) x H, where H = standing height and A = age; this model prevents the phase shift between the adolescent growth spurt in length and lung volume from leading to an age-dependent bias in predicted values. There was surprising agreement between most of the data sets; systematic differences are probably due to technical factors arising from ATPS-BTPS corrections and from defining the end of breath with pneumotachometer systems. Taking those into account, prediction equations for FVC, FEV1, and FEV1%FVC were developed with "lower limits of normal" which should be applicable to children and adolescents of European descent. It is proposed that the approach of analyzing available data sets should also be applied to other ventilatory indices, data collected in adults and elderly subjects, or in other ethnic groups, and that an international data base be set up to that end.

Adolescent↗

[Antibacterial therapy of acute exacerbated chronic bronchitis].

An early therapy of the acute exacerbation is important for the long-term prognosis of chronic bronchitis. The aim of the therapy is to stop the progressive damage of the bronchial mucosa. The typical clinical symptoms and the knowledge of the usual pathogens (in at least 80% hemophilus influenzae and streptococcus pneumoniae) allow a "blind" chemotherapy with aminopenicillins, tetracyclines and the trimethoprim-sulphonamide combination as medication of choice. The treatment is successful when the purulent sputum turns mucoid within 2 to 5 days and the symptoms improve. If this does not happen, culture and antibiogram should be made and chemotherapy chosen according to the findings. The acute exacerbation can be complicated by an airway obstruction. In this case the short-term application of glucocorticoids in combination with bronchodilators and secretolytics is suggested.

Anti-Bacterial Agents↗

[Bronchospasmolytic effectiveness of controlled drug combinations].

Two groups of 10 patients each with a chronic obstructive pulmonary disease were the subjects of a comparative study of the effectiveness of 240 mg theophyllinethylendiamine (Euphyllin) and a combined medication consisting of 25 mg theophyllin, 85 mg etophyllin, 30 mg papaverine and 0.1 mg atropine methylnitrate (Perphyllon). Oscillatory resistance (measured with the Siregnost FD 5) and the circulatory parameters pulse and blood pressure were studied. A statistically significant bronchospasmolytic effect was found for both substances administered parenterally. It was shown, however, that the combined medication worked faster, longer and 4 to 5 times more effectively than theophyllinethylendiamine. The possible causes of the differences are discussed. Clinically, the cardiovascular side effects of the combined medication are to be classified as slight. The tested medication has a favorable therapeutic spectrum as a result of the low dosage of the individual substances.

Airway Resistance↗

BTPS correction with dynamic spirometers.

In order to determine the requirements for a proper temperature correction of expired volumes, the temperature of the expired air in the bellows of a dynamic spirometer (Vitalograph) was measured in 10 and 5 subjects at 24 and 12.2 degrees C ambient temperature, respectively. During the short period of forced expiration there was a significant temperature decrease, which showed a linear relationship to the ambient temperature. Temperature differences up to 12-15% occurred within seconds; consequently, the values obtained in bellows-type spirometers for FEV1 and FVC have to be corrected to BTPS at room temperature. There was no correlation between the degree of temperature decrease and the magnitude of expiratory volume. For routine clinical work it suffices to use the room temperature as the variable.

Adult↗

Clinical experience with a bronchospasmolytic aerosol combination.

A comparative study with different bronchospasmolytic inhalers (fenoterol, ipratropium bromide, combination IK-6) was done with ten patients with obstructive airway disease. After a delayed initial effect (owing to the propellant gas) ipratropium bromide showed a bronchospasmolytic effect as good as fenoterol, but without circulatory side effects. The combination with low dosed fenoterol (Berodual) produced equally good subjective and objective results with less side effects than the high dosed fenoterol. These results should form the basis for an optimal long term treatment.

Adult↗